Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | REGN5093 |
Synonyms | |
Therapy Description |
REGN5093 is a bispecific MET antibody that targets two different epitopes on MET, potentially leading to degradation of MET and decreased tumor cell growth (PMID: 37059804, NCI Drug Dictionary). |